Elevation Oncology (ELEV) Earnings Date & Reports

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELEV is expected to report earnings to fall 16.13% to -20 cents per share on August 06

Elevation Oncology ELEV Stock Earnings Reports

Q2'25

Est.

$-0.20

Q1'25

Missed

by $0.04

Q4'24

Beat

by $0.04

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.04

The last earnings report on May 14 showed earnings per share of -23 cents, missing the estimate of -20 cents. With 290.21K shares outstanding, the current market capitalization sits at 17.84M.

View a ticker or compare two or three

Compare

ELEV